Ophthalmology Doctors in Covington, LA Accepting Medicare

6 Ophthalmology doctors found. Showing 1 - 6

Dr. Satya Vardhan Reddy, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 128 Lakeview Cir, Covington, LA 70433 Phone: 985-893-8290    Fax: 985-893-8291

Richard O Bessent, M. D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1120 N Highway 190, Covington, LA 70433 Phone: 985-893-5777    Fax: 985-892-6285

Kyle Valentino Acosta, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 200 Greenbriar Blvd, Suite B, Covington, LA 70433 Phone: 985-898-2001    Fax: 985-898-2909

Dr. Emmett Colin Mccomiskey, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 604 W 13th Ave, Covington, LA 70433 Phone: 985-871-0070    Fax: 985-871-0046

Dr. Keith E Cangelosi, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 604 W 13th Ave, Covington, LA 70433 Phone: 985-871-0070    Fax: 985-871-0046

Mrs. Wendy Grim Doneyhue, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1000 Ochsner Boulevard, Covington, LA 70433 Phone: 985-639-3777

News Archive

New system detects residues of livestock drugs in baby food preparations

The quantities are very small, but in milk powder and in meat-based baby food, residues of drugs given to livestock were found. Researchers from the University of Almeria have developed a system to analyse these substances quickly and precisely.

Blowdown evaporator that's automation-ready

The Ultravap Levante from Porvair Sciences is a next generation nitrogen blowdown evaporator designed to meet the needs of the modern automated laboratory.

EMEA informs Antigenics on a negative opinion for Oncophage MAA

Antigenics Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP), of the European Medicines Agency (EMEA), has verbally informed the Company at an oral meeting to anticipate a negative opinion on the marketing authorization application (MAA) for Oncophage (vitespen) in early-stage, localized renal cell carcinoma (kidney cancer).

Stem-cell research ban temporarily lifted in appeals court

On Friday, an appeals court temporarily stayed a judge's ban on the federal government's funding of embryonic stem-cell research, the The Associated Press/The Philadelphia Inquirer reports. "The National Institutes of Health said it was resuming its own research and would again evaluate applications from scientists who are seeking taxpayer money to do the work, a process that has been frozen since late last month."

Epizyme receives patent for drug candidate for genetically defined type of non-Hodgkin lymphomas

Epizyme, Inc., a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, announced today that it has received a Notice of Issuance from the U.S. Patent and Trademark Office for its patent application entitled "ARYL-OR HETEROARYL-SUBSTITUTED BENZENE COMPOUNDS", U.S. Patent No.: 8,410,088.

Read more Medical News

› Verified 8 days ago